Possible endogenous agonist mechanism for the activation of secretin family G protein-coupled receptors

Molecular Pharmacology

Volumn 70, Issue 1, 2006, Pages 206-213

  Dong, Maoqing ^a   Pinon, Delia I ^a   Asmann, Yan W ^a   Miller, Laurence J ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ASPARTIC ACID; BENZOYLALANYLALANYL DEXTRO TRYPTOPHYLPHENYLALANYL DEXTRO PROLYLPROLYLNORLEUCINAMIDE; CALCITONIN RECEPTOR; CYCLIC AMP; CYCLOPEPTIDE; CYSTEINE; DOCKING PROTEIN; EPITOPE; FATTY ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; MEMBRANE PROTEIN; SECRETIN; SYNTHETIC PEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACYLATION; AGONIST; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CELL STIMULATION; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CHO CELL; CONTROLLED STUDY; CYCLIZATION; DRUG MECHANISM; MOLECULAR MODEL; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; RAT;

EID: 33745267721     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.021840     Document Type: Article

References (35)

1. Asmann YW, Dong M, Ganguli S, Hadac EM, and Miller LJ (2000) Structural insights into the amino-terminus of the secretin receptor: I. Status of cysteine and cystine residues. Mol Pharmacol 58:911-919.
2. Bisello A, Adams AE, Mierke DF, Pellegrini M, Rosenblatt M, Suva LJ, and Chorev M (1998) Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies. J Biol Chem 273:22498-22505.
3. Couvineau A, Gaudin P, Maoret JJ, Rouyer-Fessard C, Nicole P, and Laburthe M (1995) Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP. Biochem Biophys Res Commun 206:246-252.
4. Dong M, Asmann YW, Zang M, Pinon DI, and Miller LJ (2000) Identification of two pairs of spatially approximated residues within the carboxyl terminus of secretin and its receptor. J Biol Chem 275:26032-26039.
5. Dong M, Li Z, Pinon DI, Lybrand TP, and Miller LJ (2004a) Spatial approximation between the amino terminus of a peptide agonist and the top of the sixth transmembrane segment of the secretin receptor. J Biol Chem 279:2894-2903.
6. Dong M, Li Z, Zang M, Pinon DI, Lybrand TP, and Miller LJ (2003) Spatial approximation between two residues in the mid-region of secretin and the amino terminus of its receptor. Incorporation of seven sets of such constraints into a three-dimensional model of the agonist-bound secretin receptor. J Biol Chem 278:48300-48312.
7. Dong M, Pinon DI, Cox RF, and Miller LJ (2004b) Importance of the amino terminus in secretin family G protein-coupled receptors: intrinsic photoaffinity labeling establishes initial docking constraints for the calcitonin receptor. J Biol Chem 279:1167-1175.
8. Dong M, Pinon DI, Cox RF, and Miller LJ (2004c) Molecular approximation between a residue in the amino-terminal region of calcitonin and the third extracellular loop of the class B G protein-coupled calcitonin receptor. J Biol Chem 279:31177-31182.
9. Dong M, Pinon DI, and Miller LJ (2005) Insights into the structure and molecular basis of ligand docking to the g protein-coupled secretin receptor using charge-modified amino-terminal agonist probes. Mol Endocrinol 19:1821-1836.
10. Dong M, Wang Y, Hadac EM, Pinon DI, Holicky E, and Miller LJ (1999a) Identification of an interaction between residue 6 of the natural peptide ligand and a distinct residue within the amino-terminal tail of the secretin receptor. J Biol Chem 274:19161-19167.
11. Dong M, Wang Y, Pinon DI, Hadac EM, and Miller LJ (1999b) Demonstration of a direct interaction between residue 22 in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffinity labeling. J Biol Chem 274:903-909.
12. Dong M, Zang M, Pinon DI, Li Z, Lybrand TP, and Miller LJ (2002) Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus. Mol Endocrinol 16:2490-2501.
13. Ganguli SC, Park CG, Holtmann MH, Hadac EM, Kenakin TP, and Miller LJ (1998) Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis. J Pharmacol Exp Ther 286:593-598.
14. Godfrey P, Rahal JO, Beamer WG, Copeland NG, Jenkins NA, and Mayo KE (1993) GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4:227-232.
15. Gourlet P, Vilardaga JP, De Neef P, Waelbroeck M, Vandermeers A, and Robberecht P (1996) The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors. Peptides 17:825-829.
16. Grace CR, Perrin MH, DiGruccio MR, Miller CL, Rivier JE, Vale WW, and Riek R (2004) NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor. Proc Natl Acad Sci USA 101:12836-12841.
17. Hadac EM, Ghanekar DV, Holicky EL, Pinon DI, Dougherty RW, and Miller LJ (1996) Relationship between native and recombinant cholecystokinin receptors: role of differential glycosylation. Pancreas 13:130-139.
18. Holtmann MH, Ganguli S, Hadac EM, Dolu V, and Miller LJ (1996) Multiple extracellular loop domains contribute critical determinants for agonist binding and activation of the secretin receptor. J Biol Chem 271:14944-14949.
19. Holtmann MH, Hadac EM, and Miller LJ (1995) Critical contributions of aminoterminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors. J Biol Chem 270:14394-14398.
20. Ji TH, Grossmann M, and Ji I (1998) G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J Biol Chem 273:17299-17302.
21. Juppner H, Schipani E, Bringhurst FR, McClure I, Keutmann HT, Potts JT Jr, Kronenberg HM, Abou-Samra AB, Segre GV, and Gardella TJ (1994) The extracellular amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34). Endocrinology 134:879-884.
22. Lerner DJ, Chen M, Tram T, and Coughlin SR (1996) Agonist recognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function. J Biol Chem 271:13943-13947.
23. Li D and Elbert DL (2002) The kinetics of the removal of the N-methyltrityl (Mtt) group during the synthesis of branched peptides. J Pept Res 60:300-303.
24. Lin SC, Lin CR, Gukovsky I, Lusis AJ, Sawchenko PE, and Rosenfeld MG (1993) Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature (Lond) 364:208-213.
25. Lisenbee CS, Dong M, and Miller LJ (2005) Paired cysteine mutagenesis to establish the pattern of disulfide bonds in the functional intact secretin receptor. J Biol Chem 280:12330-12338.
26. Nystedt S, Emilsson K, Wahlestedt C, and Sundelin J (1994) Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 91:9208-9212.
27. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, et al. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science (Wash DC) 289:739-745.
28. Pearson RK, Miller LJ, Hadac EM, and Powers SP (1987) Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor. J Biol Chem 262:13850-13856.
29. Pham V, Wade JD, Purdue BW, and Sexton PM (2004) Spatial proximity between a photolabile residue in position 19 of salmon calcitonin and the amino terminus of the human calcitonin receptor. J Biol Chem 279:6720-6729.
30. Powers SP, Pinon DI, and Miller LJ (1988) Use of N,O-bis-Fmoc-D-Tyr-ONSu for introduction of an oxidative iodination site into cholecystokinin family peptides. Int J Pept Protein Res 31:429-434.
31. Schwartz TW and Rosenkilde MM (1996) Is there a 'lock' for all agonist 'keys' in 7TM receptors? Trends Pharmacol Sci 17:213-216.
32. Ulrich CD 2nd, Holtmann M, and Miller LJ (1998) Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors. Gastroenterology 114:382-397.
33. Ulrich CD 2nd, Pinon DI, Hadac EM, Holicky EL, Chang-Miller A, Gates LK, and Miller LJ (1993) Intrinsic photoaffinity labeling of native and recombinant rat pancreatic secretin receptors. Gastroenterology 105:1534-1543.
34. Vassart G, Pardo L, and Costagliola S (2004) A molecular dissection of the glycoprotein hormone receptors. Trends Biochem Sci 29:119-126.
35. Zang M, Dong M, Pinon DI, Ding XQ, Hadac EM, Li Z, Lybrand TP, and Miller LJ (2003) Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor. Mol Pharmacol 63:993-1001.